M
Microba Life Sciences Ltd
ASX:MAP
Microba Life Sciences Ltd
ASX:MAP
Price:
0.077
AUD
-3.75%
Market Closed
Market Cap:
AU$46.9m
Cash Flow Statement
Cash Flow Statement
Microba Life Sciences Ltd
Microba Life Sciences Ltd
Currency: AUD
| Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||
| Stock-Based Compensation |
1
|
1
|
0
|
1
|
1
|
1
|
1
|
|
| Cash Taxes Paid |
(0)
|
0
|
(0)
|
0
|
(0)
|
(0)
|
0
|
|
| Cash Interest Paid |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Change in Working Capital |
3
|
5
|
4
|
1
|
7
|
13
|
7
|
|
| Cash from Operating Activities |
(10)
N/A
|
(11)
-2%
|
(12)
-16%
|
(20)
-61%
|
(16)
+22%
|
(7)
+57%
|
(12)
-80%
|
|
| Investing Cash Flow | ||||||||
| Capital Expenditures |
(2)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(3)
|
|
| Other Items |
0
|
0
|
0
|
(10)
|
(10)
|
0
|
0
|
|
| Cash from Investing Activities |
(2)
N/A
|
(3)
-74%
|
(3)
+1%
|
(13)
-328%
|
(14)
-9%
|
(4)
+71%
|
(3)
+29%
|
|
| Financing Cash Flow | ||||||||
| Net Issuance of Common Stock |
31
|
48
|
18
|
20
|
20
|
0
|
6
|
|
| Net Issuance of Debt |
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
0
|
(0)
|
|
| Other |
(2)
|
(3)
|
(1)
|
(1)
|
(1)
|
0
|
(0)
|
|
| Cash from Financing Activities |
29
N/A
|
45
+54%
|
17
-63%
|
18
+11%
|
18
0%
|
0
-99%
|
6
+2 675%
|
|
| Change in Cash | ||||||||
| Effect of Foreign Exchange Rates |
1
|
1
|
0
|
0
|
(0)
|
(0)
|
0
|
|
| Net Change in Cash |
18
N/A
|
32
+81%
|
1
-95%
|
(14)
N/A
|
(11)
+21%
|
(11)
+6%
|
(9)
+13%
|
|
| Free Cash Flow | ||||||||
| Free Cash Flow |
(12)
N/A
|
(14)
-13%
|
(15)
-11%
|
(23)
-50%
|
(20)
+14%
|
(11)
+47%
|
(15)
-40%
|
|
Switch to:
Switch to:
See Also
Discover More
